Recent Study: XEPTAGEN SpA - Product Pipeline Analysis, 2014 Update
Xeptagen SpA (Xeptagen) is a healthcare service provider. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. Its products include HEPA AFP-IC, COLONIC, HEPA AB, HEPA IC, PROSTATEIC and SCCALISA. The company develops an optoelectronic biochip for the determination of tumor molecular markers. It conducts research on developing biochips for the simultaneous detection of biomarkers-IgM immunecomplexes. The company has partnership with Associazione ABO, Olivetti I-jet S.p.A, University of Bologna,...
View full press release